FDA gets to grips with pharmacogenomics:
This article was originally published in Clinica
The US FDA wants to meet with officials from industry to learn about the demands involved in developing pharmacogenomic products. The agency will use the comments to help shape an upcoming guidance document on the topic. The day-long meeting at the Marriott Crystal Gateway Hotel in Arlington County, Virginia, will take place on July 29 from 8 am. Register by July 26, and submit comments by August 30. For more information, contact the meeting's co-sponsor, the Drug Information Association at email: firstname.lastname@example.org
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.